.0,6935390.0,2016-11-13 20:50:13,"Tuscany, Italy",Italy,Meningitis - Neisseria,Humans,?id=20161113.4626569,"PRO/EDR> Meningitis, meningococcal - Italy (06): (TC) duration of vaccine effectiveness","MENINGITIS, MENINGOCOCCAL - ITALY (06): (TUSCANY) DURATION OF VACCINE EFFECTIVENESS***********************************************************************************A ProMED-mail post<http://www.promedmail.org>ProMED-mail is a program of theInternational Society for Infectious Diseases<http://www.isid.org>Date: Sun 23 Oct 2016From: Pasquale Urbano <micro@unifi.it> [edited]Local press reports a new case of meningococcal meningitis in a 9-year-old girl from Cascina, province of Pisa, Tuscany. The case is particularly worrying, because the girl had been vaccinated in 2009. [Her] clinical condition [is] satisfactory, and contacts are being given prophylaxis.Tuscany has had a peak morbidity for _N. meningitis_ infection, with 31 cases in 2015 and 24 so far in 2016, mostly by type C. This is the 11th case in previously vaccinated subjects.The Regional health service has launched a vast vaccination campaign, reaching about 1 million persons in the areas most affected; at present it is urging pediatricians and practitioners to promote a booster or recall vaccination after 5 years.References----------1.<http://firenze.repubblica.it/cronaca/2016/11/10/news/pisa_bambina_di_9_anni_con_meningite_c-151750194/>.2. <http://www.lanazione.it/pisa/cronaca/meningite-scuola-1.2671781>.--Communicated by:Pasquale UrbanoDept. of Public Health,University of Florence (retired)Florence, Italy<micro@unifi.it>[ProMED-mail thanks Prof. Urbano for his continued contributions.This is another case in which an individual developed invasive meningococcal disease (IMD) due to serogroup C after having been recently vaccinated against _N. meningitis_ type C with a meningococcal serogroup C conjugate (MCC) vaccine in the campaign in the Tuscany Region to curb the IMD outbreak. A discussion on the duration of protection afforded by the MCC vaccine can be found in the ProMED-mail post ""Meningitis, meningococcal - Italy (05): (TC) fatal, sg C, more cases 20161024.4582016.""Cascina is a town in the province of Pisa in the Italian region Tuscany, located about 60 km (approx. 37 mi) west of Florence <https://en.wikipedia.org/wiki/Cascina>. Tuscany is a region in central Italy with a population of about 3.8 million inhabitants (2013); the regional capital is Florence <https://en.wikipedia.org/wiki/Tuscany>. A map of administrative divisions in Tuscany can be found at <https://en.wikipedia.org/wiki/Tuscany#Administrative_divisions>. - Mod.MLA HealthMap/ProMED-mail map can be accessed at: <http://healthmap.org/promed/p/15523>.][See Also:Meningitis, meningococcal - Italy (05): (TC) fatal, sg C, more cases 20161024.4582016Meningitis, meningococcal - Italy (04): (TC) fatal, sg C, genotype, epidemiology 20160325.4118731Meningitis, meningococcal - Italy (03): (TC) fatal, sg C, genotype, RFI 20160306.4073441Meningitis, meningococcal - Italy (02): (TC) fatal, sg C, RFI 20160305.4071047Meningitis, meningococcal - Italy (TC): increased incidence, sg. C 20160210.40097972015----Meningitis, meningococcal - UK: emergence of serogroup W, changed vaccine policy 20150926.3673122Meningitis, meningococcal - Europe (02): (Sweden, UK) ex Japan, Boy Scouts alert 20150826.3604861Meningitis, meningococcal - Europe: (Sweden, UK) ex Japan, Boy Scouts, RFI 20150820.3591304Meningitis, meningococcal - USA (03): (MN,IL) fatal, MSM, vaccine 20150718.3520169Meningitis, meningococcal - USA (02): (IL) fatal, MSM, vaccine, RFI 20150711.3502722Meningitis, meningococcal - Ireland: 2010-2013, ext. family, sg.B, sg.B vaccine 20150529.3394758Meningitis, meningococcal - France: (Paris) serogroup C, MSM, vaccination 20150124.3116307].................................................ml/ao/dk"
